Advertisement

Is Fever Beneficial?

Chapter
  • #x203A; Fever has a long evolutionary history, which by itself supports the hypothesis that fever is an adaptive host response to infection.

  • › There is considerable evidence that fever promotes host defense against infection.

  • › Complications and mortality associated with high fever >40°C are closely related to the severity of the underlying disease, not to the level of fever.

  • › Fever is effectively controlled by the hypothalamic centre and therefore does not climb up relentlessly. Temperatures >42°C are often caused by hyperthermia, not by fever.

  • › If the febrile child is comfortable, there is little reason to support the practice of routine use of antipyretic medication.

  • › Parental education is critical in the management of the febrile child.

  • › Antipyretics do not prevent febrile seizures.

  • › There is a conflict between research evidence supporting a positive role of fever and the demands of current practice that fever be abolished.

Keywords

Febrile Seizure Sodium Salicylate Febrile Episode Febrile Convulsion Febrile Child 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kluger MJ, Kozak W, Mayfield KP. Fever and Immunity, in Psychoneuroimmunology, Third Edition, Vol. 1, Academic Press, San Diego. 2001, pp. 687–702Google Scholar
  2. 2.
    Osawa E, Muschel LH. Studies relating to the serum resistance of certain Gram-negative bacteria. J Exp Med 1964; 119: 41–51PubMedCrossRefGoogle Scholar
  3. 3.
    Lwoff A. Factors influencing the evolution of viral diseases of the cellular level and in the organism. Bacteriol Rev 1959; 23: 109–24PubMedGoogle Scholar
  4. 4.
    Yerushalmi A, Lwoff A. Traitment du coryza infectieux et des rhinitis persistantes allergiques par la thermotherapie. Comp Rendus Seances. Acad Sci (Ser D) 1980; 291: 957–9Google Scholar
  5. 5.
    Wong VK, Hitchcock W, Mason WH. Meningococcal infections in children: a review of 100 cases. Pediatr Infect Dis J 1989; 8: 224–7PubMedGoogle Scholar
  6. 6.
    El-Radhi AS, Rostila T, Vesikari T. Association of high fever and short bacterial excretion after salmonellosis. Arch Dis Child 1992; 67: 531–2PubMedCrossRefGoogle Scholar
  7. 7.
    Nahas GG, Tannieres ML, Lennon J F. Direct measurement of leukocyte motility: effects of pH and temperature. Proc Soc Exp Biol Med 1971; 138: 350–2PubMedGoogle Scholar
  8. 8.
    Duff G W, Durum SK. Fever and immunoregulation: hyperthermia, interleukin 1 and 2, and T-cell proliferation. Yale J Biol Med 1982; 55: 437–42PubMedGoogle Scholar
  9. 9.
    Murphy PA, Hanson D F, Guo YN, et al. The effects of variations in pH and temperature on the activation of mouse thymocytes by both forms of rabbit interleukin-1. Yale J Biol Med 1985; 58: 115–23PubMedGoogle Scholar
  10. 10.
    Dinarello CA, Bernstein HA, Duff G W, et al. Mechanisms of fever induced by recombinant human interferon. J Clin Invest 1984; 74: 906–13PubMedCrossRefGoogle Scholar
  11. 11.
    Heron I, Berg K, Cantel K. Regulatory effect of interferon on T cell in vitro. J Immunol 1976; 17: 1370–3Google Scholar
  12. 12.
    Mackowiak PA, Marling-Cason M, Cohen RL. Effects of temperature on antimicrobial sus ceptibility of bacteria. J Infect Dis 1982; 145: 550–53PubMedGoogle Scholar
  13. 13.
    Donato V, Zurlo A, Nappa M, et al. Multicentre experience with combined hyperthermia and radiation therapy in the treatment of superficially located non-Hodgkin's lymphomas. J Exp Clin Cancer Res. 1997; 16: 87–90PubMedGoogle Scholar
  14. 14.
    Kluger MJ, Ringler DH, Anver MR. Fever and survival. Science 1975; 188, 166–8PubMedCrossRefGoogle Scholar
  15. 15.
    Bernheim HA, Kluger MJ. Fever: of drug-induced antipyresis on survival. Science 1976; 193: 237–9PubMedCrossRefGoogle Scholar
  16. 16.
    Graham NH, Burrell CJ, Douglas RM, et al. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding and clinical status in rhinovirus-infected vol unteers. Infect Dis 1990; 162: 1277–82Google Scholar
  17. 17.
    Doran TF, Angelis CD, Baumgarder RA, et al. Acetaminophen: more harm than good in chickenpox? Pediatr 1989; 114: 1045–8CrossRefGoogle Scholar
  18. 18.
    Sugimura T, Fujimoto T, Motoyama T, et al. Risks of antipyretics in young children with fever due to infectious diseases. Acta Paediatr Jpn 1994; 36: 375–8PubMedGoogle Scholar
  19. 19.
    Muschenheim C, Duerschrer DR, Hardy JD, et al. Hypothermia in experimental infections. Infect Dis 1943; 72: 187–96Google Scholar
  20. 20.
    Husseini RH, Sweet C, Collie MH, et al. Elevation of nasal viral levels by suppression of fever in ferrets infected with influenza viruses of differing virulence. Infect Dis 1982; 145: 520–4Google Scholar
  21. 21.
    El-Radhi AS, Jawad MJ, Mansor N, et al. Infection in neonatal hypothermia. Arch Dis Child 1983; 58: 143–5PubMedCrossRefGoogle Scholar
  22. 22.
    Williams LK, Peterson EL, Ownby DR, et al. The relationship between early fever and allergic sensitization at age 6 to 7 years. J Allergy Clin Immunol 2004; 113: 291–6PubMedCrossRefGoogle Scholar
  23. 23.
    Custovic A. The hygiene hypothesis revisited: pros and cons. Asthma and immunology 60th anniversary meeting, Denver, Colorado, March 7–12, 2003Google Scholar
  24. 24.
    Albonico HU, Braker HU, Husler J. Febrile infectious childhood disease in the history of cancer patients and matched control. Med Hypotheses 1998; 51: 315–20PubMedCrossRefGoogle Scholar
  25. 25.
    Schmitt BD. Fever phobia. Am J Dis Child 1980; 134: 176–81PubMedGoogle Scholar
  26. 26.
    May A, Bauchner H. Fever phobia: the pediatrician's contribution. Pediatrics 1992; 90: 851–4PubMedGoogle Scholar
  27. 27.
    Ekholm E, Niemineva K. On convulsions in early childhood and their prognosis. Acta Paediatr 1950; 39: 481–501PubMedCrossRefGoogle Scholar
  28. 28.
    Rosman N P. Febrile Convulsions, in Fever: Basic Mechanisms and Management, Second Edition, edited by P.A. Mackowiak. Lippincot, Philadelphia. 1997, pp. 267–77Google Scholar
  29. 29.
    Kramer MS, Naimark L, Leduc DG, et al. Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin. Lancet 1991; 337: 591–4PubMedCrossRefGoogle Scholar
  30. 30.
    El-Radhi AS, Barry W. Do antipyretics prevent febrile convulsions? Arch Dis Child 2003; 88: 641–2PubMedCrossRefGoogle Scholar
  31. 31.
    Schnaiderman D, Lahat E, Sheefer T, et al. Antipyretic effectiveness of acetaminophen in febrile seizures: ongoing prophylaxis versus sporadic usage. Eur J Pediatr 1993; 152: 747–9PubMedCrossRefGoogle Scholar
  32. 32.
    Van Stuijvenberg M, Derksen-Lubsen G, Steyerberg E W, et al. Randomized, controlled trial of ibuprofen syrup administered during febrile illnesses to prevent febrile recurrences. Pedi atrics 1998; 102: 1–7Google Scholar
  33. 33.
    Van Esch A, Steyerberg E W, Moll HA, et al. A study of the efficacy of antipyretic drugs in the prevention of febrile seizure recurrence. Ambul Child Health 2000; 6: 19–26CrossRefGoogle Scholar
  34. 34.
    Meremikwu M, Oyo-Ita A. Paracetamol for treating fever in children. Cochrane Database Syst Rev 2002; 4Google Scholar
  35. 35.
    El-Radhi AS. Lower degree of fever is associated with increased risk of subsequent convul sions. Eur J Paediatr Neuro 1998; 2: 91–6CrossRefGoogle Scholar
  36. 36.
    Offringa M, Derksen-Lubsen G, Bossuyt P. Seizure recurrence after a first febrile seizure: a multivariate approach. Dev Med Child Neurol 1992; 34: 15–24PubMedCrossRefGoogle Scholar
  37. 37.
    Azzimondi G, Bassein L, Nonino F, et al. Fever in acute stroke worsens prognosis. Stroke 1995; 26:2040–43PubMedGoogle Scholar
  38. 38.
    Kammersgaard L P, Jorgensen HS, et al. Stroke 2002, 33: 1759–62PubMedCrossRefGoogle Scholar
  39. 39.
    Pollheimer J, Zellner M, Eliasen MM, et al. Increased susceptibility of glutamine-depleted monocytes to fever-range hyperthermia: the role of 70-kDa heat shock protein. Ann Surg 2005; 241: 349–55PubMedCrossRefGoogle Scholar
  40. 40.
    Novak F, Heyland DK, Avenell A, et al. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002; 30: 2022–9PubMedCrossRefGoogle Scholar
  41. 41.
    El-Radhi AS, Barry W, Patel S. Association of fever and severe clinical course in bronchiolitis. Arch Dis Child 1999; 81: 231–4PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Personalised recommendations